HKD 2.95
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.94 Billion HKD | 24.72% |
2022 | 1.56 Billion HKD | -7.53% |
2021 | 1.68 Billion HKD | 53.53% |
2020 | 1.09 Billion HKD | 25.15% |
2019 | 878.94 Million HKD | -15.98% |
2018 | 1.04 Billion HKD | 23.31% |
2017 | 848.35 Million HKD | -9.24% |
2016 | 934.73 Million HKD | -16.94% |
2015 | 1.12 Billion HKD | 208.95% |
2014 | 364.24 Million HKD | -19.95% |
2013 | 455.01 Million HKD | 48.68% |
2012 | 306.03 Million HKD | 252.48% |
2011 | 86.82 Million HKD | 30.38% |
2010 | 66.59 Million HKD | 166.38% |
2009 | 25 Million HKD | -88.14% |
2008 | 210.8 Million HKD | -12.73% |
2007 | 241.54 Million HKD | 492.99% |
2006 | 40.73 Million HKD | 156.79% |
2005 | 15.86 Million HKD | -7.86% |
2004 | 17.21 Million HKD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 2.71 Billion HKD | 0.0% |
2023 FY | 1.94 Billion HKD | 24.72% |
2023 Q4 | 1.94 Billion HKD | 0.0% |
2023 Q2 | 1.7 Billion HKD | 0.0% |
2022 Q4 | 1.56 Billion HKD | 0.0% |
2022 FY | 1.56 Billion HKD | -7.53% |
2022 Q2 | 1.11 Billion HKD | 0.0% |
2021 FY | 1.68 Billion HKD | 53.53% |
2021 Q4 | 1.68 Billion HKD | 0.0% |
2021 Q2 | 1.33 Billion HKD | 0.0% |
2020 Q2 | 1.09 Billion HKD | 0.0% |
2020 FY | 1.09 Billion HKD | 25.15% |
2020 Q4 | 1.09 Billion HKD | 0.0% |
2019 Q2 | 916.73 Million HKD | 0.0% |
2019 Q4 | 878.94 Million HKD | 0.0% |
2019 FY | 878.94 Million HKD | -15.98% |
2018 Q4 | 1.04 Billion HKD | 0.0% |
2018 FY | 1.04 Billion HKD | 23.31% |
2018 Q2 | 737.41 Million HKD | 0.0% |
2017 Q4 | 848.35 Million HKD | 0.0% |
2017 FY | 848.35 Million HKD | -9.24% |
2017 Q2 | 720.87 Million HKD | 0.0% |
2016 Q4 | 934.73 Million HKD | 0.0% |
2016 FY | 934.73 Million HKD | -16.94% |
2016 Q2 | 1.08 Billion HKD | 0.0% |
2015 FY | 1.12 Billion HKD | 208.95% |
2015 Q4 | 1.12 Billion HKD | 0.0% |
2015 Q2 | 663.42 Million HKD | 0.0% |
2014 Q2 | 684.16 Million HKD | 0.0% |
2014 Q4 | 364.24 Million HKD | 0.0% |
2014 FY | 364.24 Million HKD | -19.95% |
2013 Q4 | 455.01 Million HKD | 0.0% |
2013 Q2 | 439.7 Million HKD | 0.0% |
2013 FY | 455.01 Million HKD | 48.68% |
2012 FY | 306.03 Million HKD | 252.48% |
2012 Q2 | 57.5 Million HKD | 0.0% |
2012 Q4 | 306.03 Million HKD | 0.0% |
2011 Q4 | 86.82 Million HKD | 0.0% |
2011 FY | 86.82 Million HKD | 30.38% |
2011 Q2 | 153.04 Million HKD | 0.0% |
2010 Q4 | 66.59 Million HKD | 0.0% |
2010 Q2 | 126.58 Million HKD | 0.0% |
2010 FY | 66.59 Million HKD | 166.38% |
2009 Q4 | 25 Million HKD | 0.0% |
2009 FY | 25 Million HKD | -88.14% |
2008 FY | 210.8 Million HKD | -12.73% |
2007 FY | 241.54 Million HKD | 492.99% |
2006 FY | 40.73 Million HKD | 156.79% |
2005 FY | 15.86 Million HKD | -7.86% |
2004 FY | 17.21 Million HKD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Pak Fah Yeow International Limited | 2.07 Million HKD | -93849.298% |
Grand Pharmaceutical Group Limited | 990.02 Million HKD | -96.718% |
Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -1562.826% |
Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -605.13% |
Qianhai Health Holdings Limited | - HKD | -Infinity% |
Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -2657.189% |
Essex Bio-Technology Limited | 36.05 Million HKD | -5301.4% |
Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -15114.186% |
PuraPharm Corporation Limited | 81.09 Million HKD | -2301.647% |
JBM (Healthcare) Limited | 43.8 Million HKD | -4346.502% |
Jacobson Pharma Corporation Limited | 592.2 Million HKD | -228.87% |
China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 88.28% |